Phenotypic, functional and molecular genetic changes in the CD8+ T cell population in HIV infection

1997 ◽  
Vol 56 (1-3) ◽  
pp. 362-363
Author(s):  
M Grant
1997 ◽  
Vol 56 ◽  
pp. 362-363
Author(s):  
M. Grant ◽  
S. Kottilil ◽  
T. Marshall ◽  
M. Gallant ◽  
I. Pardoe ◽  
...  

2014 ◽  
Vol 9 (5) ◽  
pp. 500-505 ◽  
Author(s):  
Joseph C. Mudd ◽  
Michael M. Lederman
Keyword(s):  
T Cell ◽  

2011 ◽  
Vol 186 (4) ◽  
pp. 2106-2116 ◽  
Author(s):  
Marta Catalfamo ◽  
Christopher Wilhelm ◽  
Lueng Tcheung ◽  
Michael Proschan ◽  
Travis Friesen ◽  
...  

2009 ◽  
Vol 206 (4) ◽  
pp. 923-936 ◽  
Author(s):  
David A. Price ◽  
Tedi E. Asher ◽  
Nancy A. Wilson ◽  
Martha C. Nason ◽  
Jason M. Brenchley ◽  
...  

Despite the pressing need for an AIDS vaccine, the determinants of protective immunity to HIV remain concealed within the complexity of adaptive immune responses. We dissected immunodominant virus-specific CD8+ T cell populations in Mamu-A*01+ rhesus macaques with primary SIV infection to elucidate the hallmarks of effective immunity at the level of individual constituent clonotypes, which were identified according to the expression of distinct T cell receptors (TCRs). The number of public clonotypes, defined as those that expressed identical TCR β-chain amino acid sequences and recurred in multiple individuals, contained within the acute phase CD8+ T cell population specific for the biologically constrained Gag CM9 (CTPYDINQM; residues 181–189) epitope correlated negatively with the virus load set point. This independent molecular signature of protection was confirmed in a prospective vaccine trial, in which clonotype engagement was governed by the nature of the antigen rather than the context of exposure and public clonotype usage was associated with enhanced recognition of epitope variants. Thus, the pattern of antigen-specific clonotype recruitment within a protective CD8+ T cell population is a prognostic indicator of vaccine efficacy and biological outcome in an AIDS virus infection.


Nature ◽  
2021 ◽  
Author(s):  
Sofia V. Gearty ◽  
Friederike Dündar ◽  
Paul Zumbo ◽  
Gabriel Espinosa-Carrasco ◽  
Mojdeh Shakiba ◽  
...  

1997 ◽  
Vol 94 (18) ◽  
pp. 9848-9853 ◽  
Author(s):  
G. Pantaleo ◽  
H. Soudeyns ◽  
J. F. Demarest ◽  
M. Vaccarezza ◽  
C. Graziosi ◽  
...  

Blood ◽  
2012 ◽  
Vol 119 (21) ◽  
pp. 4928-4938 ◽  
Author(s):  
Patricia Ribeiro-dos-Santos ◽  
Emma L. Turnbull ◽  
Marta Monteiro ◽  
Agnès Legrand ◽  
Karen Conrod ◽  
...  

Abstract CD8 T cells lose the capacity to control HIV infection, but the extent of the impairment of CD8 T-cell functions and the mechanisms that underlie it remain controversial. Here we report an extensive ex vivo analysis of HIV-specific CD8 T cells, covering the expression of 16 different molecules involved in CD8 function or differentiation. This approach gave remarkably homogeneous readouts in different donors and showed that CD8 dysfunction in chronic HIV infection was much more severe than described previously: some Ifng transcription was observed, but most cells lost the expression of all cytolytic molecules and Eomesodermin and T-bet by chronic infection. These results reveal a cellular mechanism explaining the dysfunction of CD8 T cells during chronic HIV infection, as CD8 T cells are known to maintain some functionality when either of these transcription factors is present, but to lose all cytotoxic activity when both are not expressed. Surprisingly, they also show that chronic HIV and lymphocytic choriomeningitis virus infections have a very different impact on fundamental T-cell functions, “exhausted” lymphocytic choriomeningitis virus-specific cells losing the capacity to secrete IFN-γ but maintaining some cytotoxic activity as granzyme B and FasL are overexpressed and, while down-regulating T-bet, up-regulating Eomesodermin expression.


Retrovirology ◽  
2009 ◽  
Vol 6 (S3) ◽  
Author(s):  
G Makedonas ◽  
I Frank ◽  
D Guidonis ◽  
MA Ostrowski ◽  
KJ Weinhold ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document